Spellman David A 4
4 · Akebia Therapeutics, Inc. · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Spellman David A
SVP, CFO and Treasurer
Transactions
- Award
Common Stock
2021-02-26+70,000→ 70,000 total - Award
Employee Stock Option (Right to buy)
2021-02-26+120,000→ 120,000 totalExercise: $3.46Exp: 2031-02-26→ Common Stock (120,000 underlying)
Footnotes (2)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
- [F2]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.